Cargando…
Radiosensitization Effect of Talazoparib, a Parp Inhibitor, on Glioblastoma Stem Cells Exposed to Low and High Linear Energy Transfer Radiation
Despite continuous improvements in treatment of glioblastoma, tumor recurrence and therapy resistance still occur in a high proportion of patients. One underlying reason for this radioresistance might be the presence of glioblastoma cancer stem cells (GSCs), which feature high DNA repair capability....
Autores principales: | Lesueur, Paul, Chevalier, François, El-Habr, Elias A., Junier, Marie-Pierre, Chneiweiss, Hervé, Castera, Laurent, Müller, Etienne, Stefan, Dinu, Saintigny, Yannick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826933/ https://www.ncbi.nlm.nih.gov/pubmed/29483558 http://dx.doi.org/10.1038/s41598-018-22022-4 |
Ejemplares similares
-
Capture at the single cell level of metabolic modules distinguishing aggressive and indolent glioblastoma cells
por: Saurty-Seerunghen, Mirca S., et al.
Publicado: (2019) -
Combining PARP Inhibition, Radiation, and Immunotherapy: A Possible Strategy to Improve the Treatment of Cancer?
por: Césaire, Mathieu, et al.
Publicado: (2018) -
PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib
por: Ding, Xia, et al.
Publicado: (2022) -
Design, Synthesis, and In Vitro Evaluation of the Photoactivatable Prodrug of the PARP Inhibitor Talazoparib
por: Li, Jiaguo, et al.
Publicado: (2020) -
Radiosynthesis and Evaluation of Talazoparib and Its Derivatives as PARP-1-Targeting Agents
por: Zhou, Dong, et al.
Publicado: (2021)